Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block
- PMID: 17303642
- PMCID: PMC2075223
- DOI: 10.1113/jphysiol.2006.124958
Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block
Abstract
We have compared the potencies of structurally distinct channel blockers at recombinant NR1/NR2A, NR1/NR2B, NR1/NR2C and NR1/NR2D receptors. The IC50 values varied with stereochemistry and subunit composition, suggesting that it may be possible to design subunit-selective channel blockers. For dizocilpine (MK-801), the differential potency of MK-801 stereoisomers determined at recombinant NMDA receptors was confirmed at native receptors in vitro and in vivo. Since the proton sensor is tightly linked both structurally and functionally to channel gating, we examined whether blocking molecules that interact in the channel pore with the gating machinery can differentially sense protonation of the receptor. Blockers capable of remaining trapped in the pore during agonist unbinding showed the strongest dependence on extracellular pH, appearing more potent at acidic pH values that promote channel closure. Determination of pK(a) values for channel blockers suggests that the ionization of ketamine but not of other blockers can influence its pH-dependent potency. Kinetic modelling and single channel studies suggest that the pH-dependent block of NR1/NR2A by (-)MK-801 but not (+)MK-801 reflects an increase in the MK-801 association rate even though protons reduce channel open probability and thus MK-801 access to its binding site. Allosteric modulators that alter pH sensitivity alter the potency of MK-801, supporting the interpretation that the pH sensitivity of MK-801 binding reflects the changes at the proton sensor rather than a secondary effect of pH. These data suggest a tight coupling between the proton sensor and the ion channel gate as well as unique subunit-specific mechanisms of channel block.
Figures
Comment in
-
NMDA receptor antagonists: tools in neuroscience with promise for treating CNS pathologies.J Physiol. 2007 May 15;581(Pt 1):1-2. doi: 10.1113/jphysiol.2007.130732. Epub 2007 Mar 1. J Physiol. 2007. PMID: 17331982 Free PMC article. No abstract available.
Similar articles
-
Conserved structural and functional control of N-methyl-D-aspartate receptor gating by transmembrane domain M3.J Biol Chem. 2005 Aug 19;280(33):29708-16. doi: 10.1074/jbc.M414215200. Epub 2005 Jun 21. J Biol Chem. 2005. PMID: 15970596
-
NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology.J Pharmacol Exp Ther. 1997 Feb;280(2):614-20. J Pharmacol Exp Ther. 1997. PMID: 9023271
-
Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.Br J Pharmacol. 1996 Sep;119(2):195-204. doi: 10.1111/j.1476-5381.1996.tb15971.x. Br J Pharmacol. 1996. PMID: 8886398 Free PMC article.
-
Open-channel blockers of the NMDA receptor complex.Drug News Perspect. 2004 Nov;17(9):557-62. doi: 10.1358/dnp.2004.17.9.872569. Drug News Perspect. 2004. PMID: 15645013 Review.
-
Subunit- and site-specific pharmacology of the NMDA receptor channel.Prog Neurobiol. 1999 Oct;59(3):279-98. doi: 10.1016/s0301-0082(99)00007-6. Prog Neurobiol. 1999. PMID: 10465381 Review.
Cited by
-
Protons as Messengers of Intercellular Communication in the Nervous System.Front Cell Neurosci. 2018 Oct 10;12:342. doi: 10.3389/fncel.2018.00342. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30364044 Free PMC article. Review.
-
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment.Neuropharmacology. 2023 Mar 15;226:109422. doi: 10.1016/j.neuropharm.2023.109422. Epub 2023 Jan 13. Neuropharmacology. 2023. PMID: 36646310 Free PMC article. Review.
-
Brain tumors and epilepsy: pathophysiology of peritumoral changes.Neurosurg Rev. 2009 Jul;32(3):275-84; discussion 284-6. doi: 10.1007/s10143-009-0191-7. Epub 2009 Feb 11. Neurosurg Rev. 2009. PMID: 19205766 Review.
-
Mechanisms of ketamine and its metabolites as antidepressants.Biochem Pharmacol. 2022 Mar;197:114892. doi: 10.1016/j.bcp.2021.114892. Epub 2021 Dec 27. Biochem Pharmacol. 2022. PMID: 34968492 Free PMC article. Review.
-
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.Pharmacol Rev. 2018 Jul;70(3):621-660. doi: 10.1124/pr.117.015198. Pharmacol Rev. 2018. PMID: 29945898 Free PMC article. Review.
References
-
- Albers GW, Goldberg MP, Choi DW. N-Methyl-d-aspartate antagonists: ready for clinical trial in brain ischemia? Ann Neurol. 1989;25:398–403. - PubMed
-
- Andine P, Widermark N, Axelsson R, Nyberg G, Olofsson U, Martensson E, Sandberg M. Characterization of MK-801-induced behavior as a putative rat model of psychosis. J Pharmacol Exp Ther. 1999;290:1393–1408. - PubMed
-
- Antonov SM, Gmiro VE, Johnson JW. Binding sites for permeant ions in the channel of NMDA receptors and their effects on channel block. Nat Neurosci. 1998;1:451–461. - PubMed
-
- Balster RL. Drug abuse potential evaluation in animals. Br J Addict. 1991;86:1549–1558. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases